CN106912862A - 一种油茶蜂胶及其制备方法 - Google Patents
一种油茶蜂胶及其制备方法 Download PDFInfo
- Publication number
- CN106912862A CN106912862A CN201710139222.5A CN201710139222A CN106912862A CN 106912862 A CN106912862 A CN 106912862A CN 201710139222 A CN201710139222 A CN 201710139222A CN 106912862 A CN106912862 A CN 106912862A
- Authority
- CN
- China
- Prior art keywords
- propolis
- root
- mixed
- straight ladybell
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000241413 Propolis Species 0.000 title claims abstract description 83
- 229940069949 propolis Drugs 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241001122767 Theaceae Species 0.000 title description 17
- 241001412627 Adenophora liliifolia Species 0.000 claims abstract description 43
- 239000000843 powder Substances 0.000 claims abstract description 31
- 239000003921 oil Substances 0.000 claims abstract description 29
- 235000019198 oils Nutrition 0.000 claims abstract description 29
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 17
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 16
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 15
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 15
- 235000020224 almond Nutrition 0.000 claims abstract description 15
- 229940088594 vitamin Drugs 0.000 claims abstract description 15
- 229930003231 vitamin Natural products 0.000 claims abstract description 15
- 235000013343 vitamin Nutrition 0.000 claims abstract description 15
- 239000011782 vitamin Substances 0.000 claims abstract description 15
- 239000010495 camellia oil Substances 0.000 claims abstract description 14
- 239000002674 ointment Substances 0.000 claims abstract description 14
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 13
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 13
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 12
- 239000008170 walnut oil Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000012907 honey Nutrition 0.000 claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims abstract 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 51
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 13
- 239000003292 glue Substances 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 229930003270 Vitamin B Natural products 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- 235000019156 vitamin B Nutrition 0.000 claims description 6
- 239000011720 vitamin B Substances 0.000 claims description 6
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 230000010355 oscillation Effects 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 239000004411 aluminium Substances 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000005374 membrane filtration Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 9
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 description 16
- 241000256844 Apis mellifera Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000002265 prevention Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229930003448 Vitamin K Natural products 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 235000019168 vitamin K Nutrition 0.000 description 4
- 239000011712 vitamin K Substances 0.000 description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 description 4
- 229940046010 vitamin k Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 235000018597 common camellia Nutrition 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- XLSLFPQAPYONPW-WHUHBCJBSA-N (2s,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H](C#N)C1=CC=CC=C1 XLSLFPQAPYONPW-WHUHBCJBSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000209507 Camellia Species 0.000 description 2
- 241000726221 Gemma Species 0.000 description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- UNGXBWFICNLIRX-UHFFFAOYSA-N Laetrile Natural products NCC(OC1OC(C(O)C(O)C1O)C(=O)O)c2ccccc2 UNGXBWFICNLIRX-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- -1 flavanol compound Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229940068052 ginkgo biloba extract Drugs 0.000 description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241001633574 Adenophora stricta Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000256836 Apis Species 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241001550206 Colla Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000252498 Ictalurus punctatus Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Chemical class 0.000 description 1
- 229930002877 anthocyanin Chemical class 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Chemical class O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 208000011759 gum bleeding Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
本发明公开的一种油茶蜂胶及其制备方法,涉及生物医药中的保健食品技术领域,是由下列重量份的原料混合而成:茶油10‑20、沙参提取液2‑6、核桃油4‑10、蜂蜜10‑16、大豆磷脂0.5‑3、杏仁粉2‑5、蜂胶膏30‑45、柠檬酸单甘脂0.5‑3、茶多酚3‑6、维生素1‑4;其制备过程如下:㈠、混合一;㈡、混合二;㈢、混合三;㈣、混合四。本发明的油茶蜂胶具有营养十分丰富,能满足不同年龄、不同人群的保健需求等特点,适合于不同年龄、不同人群食用。
Description
技术领域
本发明涉及生物医药中的保健食品技术领域,特别是一种油茶蜂胶及其制备方法。
背景技术
蜂胶是蜜蜂从植物芽孢或树干上采集的树脂,将其混入其上腭腺、蜡腺的分泌物加工而成的一种具有芳香气味的胶状固体物。蜂胶是极为稀少的天然资源,素有“紫色黄金”之称,内含300多种营养成分,具有广泛的生理和药理作用。
目前,利用蜂胶制备的保健品较多,如中国专利(专利申请号为200710003085.9)公开的“一种棕黄色蜂胶软胶囊的制备方法”,是用食用植物油溶解蜂胶,利用蜂胶的基本组成物质,与食用植物油成份相互作用,形成蜂胶油溶物。固液分离后,固形物再溶解,浓缩后合并,调节有效成份含量至标准要求,再填充制成软胶囊,蜂胶总黄酮含量为:30MG/ML,并可调整。
另一中国专利(专利申请号为201110143776.5)公开的“蜂胶保健品及其制备方法”,以质量份数计,其组成为:蜂胶30-60份,维生素E0.5-2份,灵芝袍子多糖5-10份,茶多酚5-10份,银杏提取物5-10份,所述银杏提取物是将银杏叶用乙醇提取,经过滤得到。蜂胶保健品的制备方法,是将上述原料按比例混合,放入搅拌机充分搅拌,通过紫外线照射消毒得到产品。
还有中国专利(专利申请号为201610170646.3)公开的“一种通络理气蜂胶鸭血干及其制备方法”,其通络理气蜂胶鸭血干是由下列重量份的原料制成:黄豆120-130、绿豆30-40、0.4-0.5mol/l醋酸100-130、壳聚糖1-2、鮰鱼皮10-14、茶多酚0.2-0.4、羧甲基纤维素5-7、小麦面筋蛋白1.2-4、卵磷脂0.01-0.02、30-40%的乙醇溶液160-170、蜂胶2-3、鸭血10-14、玉米粒12-13、香菜3-4、橘络2-3、侧柏叶1.8-2、三七花1.1-2。
发明内容
本发明的目的在于提供一种营养十分丰富,能满足不同年龄、不同人群需求的保健产品,并提供其制备方法。
为实现上述目的,本发明所采取的技术措施是发明一种油茶蜂胶,是由下列重量份的原料混合而成:
茶油10-20 沙参提取液2-6 核桃油4-10
蜂蜜10-16 大豆磷脂0.5-3 杏仁粉2-5
蜂胶膏30-45 柠檬酸单甘脂0.5-3 茶多酚3-6
维生素1-4。
其优化的技术方案是由下列重量份的原料混合而成:
茶油15 沙参提取液4 核桃油7
蜂蜜14 大豆磷脂2 杏仁粉4
蜂胶膏40 柠檬酸单甘脂2 茶多酚5
维生素3。
所述维生素包括维生素C、维生素B、维生素K、维生素E中一种以上,当为两种以上时,各组分的配比为等重量份或其它比例。
所述沙参提取液是将沙参与同等重量份的水煮沸提取40-60min,过滤所得;也可以是按以下方法制备而成:将沙参洗净,切成0.1-0.5cm厚的沙参片,并将其投入1-3倍重量、体积浓度为70-85%的食用乙醇中,常温浸泡1-5h,过滤;再将经过食用乙醇浸泡过的沙参片投入1-2倍重量、重量浓度为3.0-5.0%的碳酸氢钠溶液中,在40-60℃浸泡20-40min,过滤,用清水洗涤1-2次,得处理沙参;再将处理沙参在60-70℃烘干至水分小于18%,然后处理成40目以上的沙参粉;再将沙参粉投入到2-5倍重量的沸水中,保温提取1-1.5h,过滤,得沙参水提液;再将沙参水提液在压力10-15KPa、温度40-60℃下浓缩至固形物含量为0.5-1.2g/10ml,即得沙参提取液。
所述蜂胶膏是将蜂胶溶解在同等重量份、体积浓度为50-70%的食用乙醇中,然后浓缩至无醇所得;也可以是按以下方法制备而成:先将蜂胶在-10-0℃下冷藏5-8h,再处理成8-12目的蜂胶粉;然后,将蜂胶粉投入振荡器中,同时加入2-4倍重量、体积浓度为40-65%的食用乙醇,在频率500-800Hz、室温条件下振荡处理3-6h,再加入占蜂胶粉重量1-2.5%的中性氧化铝粉,在频率1000-1500Hz、室温条件下振荡处理1-2h,过滤,得蜂胶乙醇溶液;再将蜂胶乙醇溶液在压力为1-2.5MPa、室温条件下,经磁性过滤器(型号为DHCL-12或其它型号)过滤,得蜂胶过滤液;再将蜂胶过滤液在压力2.5-5.5MPa、温度35-48℃下,经微滤膜(孔径为3-10nm)过滤,得蜂胶微滤液;再将蜂胶微滤液在压力10-15KPa、温度40-60℃下浓缩至无醇,得蜂胶浓缩液;再将蜂胶浓缩液转入烘箱中,在60-70℃下干燥至水分小于15%,即得蜂胶膏。
与此同时,还提供一种制备油茶蜂胶的方法,其制备过程如下:
㈠、混合一:将维生素类、柠檬酸单甘脂、茶多酚、沙参提取液一起放入振荡器中,在频率200-400Hz下处理1-2h,过滤,得混合液一;
㈡、混合二:将茶油、核桃油、蜂蜜以及1/2重量份的大豆磷脂一起放入振荡器中,在频率400-800Hz下处理0.5-1h,过滤,得混合液二;
㈢、混合三:将杏仁粉和余下的1/2重量份的大豆磷脂加入到蜂胶膏中,混合均匀,得混合液三;
㈣、混合四:将混合液一、混合液二按顺序缓慢加入混合液三中,边加边搅,至混匀,即成油茶蜂胶。
本发明的油茶蜂胶,采用的主要原料有茶油、维生素类、核桃油、蜂蜜、大豆磷脂、杏仁粉、茶多酚、沙参提取液、柠檬酸单甘脂和蜂胶膏。
茶油(Camellia oleiferaAbel)是山茶科植物油茶或小叶油茶的成熟种子用压榨法得到的脂肪油,茶油的食疗双重功能实际上优于橄榄油,除了两种油脂的脂肪酸组成及油脂特性、营养成分相似外,茶油还含有橄榄油所没有的特定生理活性物质茶多酚和山茶甙(即茶皂甙,或称茶皂素)。茶油富含维生素E,还含有角鲨烯与黄酮类物质,对抗癌、抗炎有着极佳的作用。
维生素(Vitamin)包括维生素C、维生素B、维生素K、维生素E中的一种或多种。维生素C能够促进骨胶原的生物合成,利于组织创伤口的更快愈合;促进氨基酸中酪氨酸和色氨酸的代谢,延长肌体寿命;改善铁、钙和叶酸的利用;改善脂肪和类脂特别是胆固醇的代谢,预防心血管病;促进牙齿和骨骼的生长,防止牙床出血;增强肌体对外界环境的抗应激能力和免疫力。维生素B包括维生素B1、维生素B2和维生素B12,维生素B的主要功效有:一是治疗白细胞减少症,二是防治因大量或长期服用异烟肼、肼屈嗪等引起的周围神经炎、失眠、不安,三是减轻抗癌药和放射治疗引起恶心、呕吐或妊娠呕吐,四是对神经组织和精神状态有良好的影响,五是能够增强身体制造红血球和保持免疫系统的功能,六是用于哮喘、疲劳、肝炎、失眠和癫痫等的治疗。维生素K又叫凝血维生素,包括维生素K1和维生素K2,具有促进血液凝固、参与骨骼代谢等功效。维生素E是一种脂溶性维生素,是最主要的抗氧化剂之一;其水解产物为生育酚,生育酚能促进性激素分泌,使男子精子活力和数量增加;使女子雌性激素浓度增高,提高生育能力,预防流产,还可用于防治男性不育症、烧伤、冻伤、毛细血管出血、更年期综合症、美容等方面、预防近视眼发生和发展。
核桃油(Juglans regia L.)是采用核桃仁为原料,压榨而成的可食用植物油。核桃油新鲜纯正、营养丰富、口感清淡,脂肪酸组态近似母乳,易被消化吸收,是儿童发育期,女性妊娠期及产后康复的高级保健食用油。核桃油的营养含量:不饱和脂肪酸含量≥92%,亚油酸Ω-6≥56%、亚麻酸Ω-3≥14%,富含天然VA、VD等营养物质。酸度≤0.5,口感清淡无异味,纯生原味,特别适合宝宝娇嫩肠胃。
蜂蜜(Apis cerana Fabr或Apis mellifera L.)具有调补脾胃、缓急止痛、润肺止咳、润肠通便、润肤生肌、解毒等功效。
大豆磷脂是从生产大豆油的油脚中提取的产物,是由甘油、脂肪酸、胆碱或胆胺所组成的酯。大豆磷脂有降低胆固醇,预防动脉硬化的作用;对高血压,脑中风,心脏病有很强的预防和控制作用;还具有使胆结石自然消失、预防糖尿病、消除青春痘和雀斑、消除和预防心肌梗塞、消除脂肪肝和预防肝硬化、健美皮肤、减肥等功效。
杏仁粉(almondpowder)是杏仁的一种加工产品,具有以下食疗效果:一是镇咳化痰、强尽喉咙气管功能、理肺、润肺、固肺、怯风寒;二是含丰富纤维质可促进肠蠕动、健胃整肠,帮助消化、治便秘;三是含维生素B17,有抗癌作用,还可增强抗过敏能力;四是含磷、铁、钙及不饱和脂肪酸,是维持人体健康的重要营养要素,每日饮用可迅速补充营养,维持体力;五是全脂杏仁粉含有49%的杏仁油,可保养皮肤,淡化色斑,使皮肤白嫩;六是具有瘦身作用;七是含天然维生素E,常吃杏仁能养颜美容,滋润皮肤;八是含有维生素B17,有抗癌作用。
茶多酚(Tea Polyphenols)是茶叶中多酚类物质的总称,包括黄烷醇类、花色苷类、黄酮类、黄酮醇类和酚酸类等。茶多酚具有很强的抗氧化性和生理活性,是人体自由基的清除剂,有助于抑制心血管疾病,有助于预防和抗癌,有助于预防和治疗辐射伤害,有助于抑制和抵抗病毒菌,有助于美容护肤,有助于醒脑提神,有助于利尿解乏,有助于降脂助消化,有助于护齿明目。
沙参(Adenophora stricta)提取液是由沙参提取的含有沙参有效成份的液体,具有养阴清肺、益胃生津等作用。
柠檬酸单甘脂具有乳化、分散、螯合、抗氧化增效、抗淀粉老化及控制脂肪凝集等作用,是优质的防溅剂,能与微量重金属络合,与抗氧化剂混合使用起增效和增溶作用。
蜂胶膏是由蜂胶(Colla Apis)加工的半成品,蜂胶是蜜蜂从植物芽孢或树干上采集的树脂,将其混入其上腭腺、蜡腺的分泌物加工而成的一种具有芳香气味的胶状固体物。蜂胶所含有的丰富而独特的生物活性物质,使其具有抗菌、消炎、止痒、抗氧化、增强免疫、降血糖、降血脂、抗肿瘤等多种功能,对人体有着广泛的医疗、保健作用。
下表是本发明的油茶蜂胶的主要成份检测数据(100克):
从上表数据可以看出,本发明的油茶蜂胶中,既含有对人体有益的不饱和脂肪酸,能降低血液胆固醇,预防动脉粥样硬化等功效,同时还含有多种有益的黄酮类物质以及糖类物质,能满足人体健康的各种需要。因此,本发明的油茶蜂胶,其营养十分丰富,且能满足不同年龄、不同人群的保健需求。
具体实施方式
以下结合实施例,对本发明作进一步的说明。下面的说明是以例举的方式,但本发明的保护范围并不局限于此。
本实施例的油茶蜂胶,是由下列重量份的原料混合而成:
茶油15 沙参提取液4 核桃油7
蜂蜜14 大豆磷脂2 杏仁粉4
蜂胶膏40 柠檬酸单甘脂2 茶多酚5
维生素3。
其具体制备过程如下:
㈠、原料准备和预处理:
⑴、沙参提取液制备:
将沙参洗净,切成0.3cm厚的沙参片,并将其投入2倍重量、体积浓度为80%的食用乙醇中,常温浸泡3h,过滤;再将经过食用乙醇浸泡过的沙参片投入2倍重量、重量浓度为4%的碳酸氢钠溶液中,在50℃浸泡30min,过滤,用清水洗涤2次,得处理沙参;再将处理沙参在65℃烘干至水分小于18%,然后处理成40目以上的沙参粉;再将沙参粉投入到4倍重量的沸水中,保温提取1.2h,过滤,得沙参水提液;再将沙参水提液在压力12KPa、温度50℃下浓缩至固形物含量为0.8g/10ml,即得沙参提取液。
⑵、蜂胶膏制备:
先将蜂胶在-5℃下冷藏6h,再处理成10目的蜂胶粉;然后,将蜂胶粉投入振荡器中,同时加入3倍重量、体积浓度为55%的食用乙醇,在频率650Hz、室温条件下振荡处理4h,再加入占蜂胶粉重量2%的中性氧化铝粉,在频率1200Hz、室温条件下振荡处理1.5h,过滤,得蜂胶乙醇溶液;再将蜂胶乙醇溶液在压力为1.8MPa、室温条件下,经磁性过滤器(型号为DHCL-12)过滤,得蜂胶过滤液;再将蜂胶过滤液在压力2.5-5.5MPa、温度35-48℃下,经微滤膜(孔径为3-10nm)过滤,得蜂胶微滤液;再将蜂胶微滤液在压力10-15KPa、温度55℃下浓缩至无醇,得蜂胶浓缩液;再将蜂胶浓缩液转入烘箱中,在60℃下干燥至水分小于15%,即得蜂胶膏。
⑶、杏仁粉准备:
将杏仁经超微粉碎成粒径小于10nm的杏仁粉。
⑷、茶多酚准备:
将茶多酚经超微粉碎成粒径小于10nm的茶多酚(粉)。
⑸、茶油准备:
选取符合国家GB11765-2003标准的茶油。
⑹、核桃油准备:
选取亚油酸含量≥56%、符合国家GB22327-2008标准的核桃油。
⑺、维生素准备:
按照等重量份配比,分别取维生素C、维生素B、维生素K、维生素E,混合均匀。
㈡、混合:
⑴、混合一:将维生素类、柠檬酸单甘脂、茶多酚、沙参提取液一起放入振荡器中,在频率300Hz下处理2h,过滤,得混合液一;
⑵、混合二:将茶油、核桃油、蜂蜜以及1/2重量份的大豆磷脂一起放入振荡器中,在频率600Hz下处理0.8h,过滤,得混合液二;
⑶、混合三:将杏仁粉和余下的1/2重量份的大豆磷脂加入到蜂胶膏中,混合均匀,得混合液三;
⑷、混合四:将混合液一、混合液二按顺序缓慢加入混合液三中,边加边搅,至混匀,即成油茶蜂胶。
本发明的油茶蜂胶为膏状,也可灌制成胶囊或其它剂型,便于食用。食用时,每天早晚各服1-2克,用于保健。
本发明的油茶蜂胶,适合于不同年龄、不同人群食用。
Claims (6)
1.一种油茶蜂胶,其特征在于是由下列重量份的原料混合而成:
2.根据权利要求1所述的油茶蜂胶,其特征在于是由下列重量份的原料混合而成:
3.根据权利要求1所述的油茶蜂胶,其特征在于:所述维生素包括维生素C、维生素B、维生素K、维生素E中一种以上,当为两种以上时,各组分的配比为等重量份或其它比例。
4.根据权利要求1所述的油茶蜂胶,其特征在于:所述沙参提取液是按以下方法制备而成:将沙参洗净,切成0.1-0.5cm厚的沙参片,并将其投入1-3倍重量、体积浓度为70-85%的食用乙醇中,常温浸泡1-5h,过滤;再将经过食用乙醇浸泡过的沙参片投入1-2倍重量、重量浓度为3.0-5.0%的碳酸氢钠溶液中,在40-60℃浸泡20-40min,过滤,用清水洗涤1-2次,得处理沙参;再将处理沙参在60-70℃烘干至水分小于18%,然后处理成40目以上的沙参粉;再将沙参粉投入到2-5倍重量的沸水中,保温提取1-1.5h,过滤,得沙参水提液;再将沙参水提液在压力10-15KPa、温度40-60℃下浓缩至固形物含量为0.5-1.2g/10ml,即得沙参提取液。
5.根据权利要求1所述的油茶蜂胶,其特征在于:所述蜂胶膏是按以下方法制备而成:先将蜂胶在-10-0℃下冷藏5-8h,再处理成8-12目的蜂胶粉;然后,将蜂胶粉投入振荡器中,同时加入2-4倍重量、体积浓度为40-65%的食用乙醇,在频率500-800Hz、室温条件下振荡处理3-6h,再加入占蜂胶粉重量1-2.5%的中性氧化铝粉,在频率1000-1500Hz、室温条件下振荡处理1-2h,过滤,得蜂胶乙醇溶液;再将蜂胶乙醇溶液在压力为1-2.5MPa、室温条件下,经磁性过滤器过滤,得蜂胶过滤液;再将蜂胶过滤液在压力2.5-5.5MPa、温度35-48℃下,经微滤膜过滤,得蜂胶微滤液;再将蜂胶微滤液在压力10-15KPa、温度40-60℃下浓缩至无醇,得蜂胶浓缩液;再将蜂胶浓缩液转入烘箱中,在60-70℃下干燥至水分小于15%,即得蜂胶膏。
6.一种如权利要求1-5中任一项所述油茶蜂胶的制备方法,其特征在于,制备过程如下:
㈠、混合一:将维生素类、柠檬酸单甘脂、茶多酚、沙参提取液一起放入振荡器中,在频率200-400Hz下处理1-2h,过滤,得混合液一;
㈡、混合二:将茶油、核桃油、蜂蜜以及1/2重量份的大豆磷脂一起放入振荡器中,在频率400-800Hz下处理0.5-1h,过滤,得混合液二;
㈢、混合三:将杏仁粉和余下的1/2重量份的大豆磷脂加入到蜂胶膏中,混合均匀,得混合液三;
㈣、混合四:将混合液一、混合液二按顺序缓慢加入混合液三中,边加边搅,至混匀,即成油茶蜂胶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710139222.5A CN106912862A (zh) | 2017-03-09 | 2017-03-09 | 一种油茶蜂胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710139222.5A CN106912862A (zh) | 2017-03-09 | 2017-03-09 | 一种油茶蜂胶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106912862A true CN106912862A (zh) | 2017-07-04 |
Family
ID=59460390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710139222.5A Pending CN106912862A (zh) | 2017-03-09 | 2017-03-09 | 一种油茶蜂胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106912862A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108056440A (zh) * | 2017-12-25 | 2018-05-22 | 云南保山嘉宏农业开发(集团)有限公司 | 印楝蜜的配方及其制备工艺 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105558968A (zh) * | 2016-01-28 | 2016-05-11 | 枣阳市圣奥养蜂专业合作社 | 灵芝黑蜂胶 |
-
2017
- 2017-03-09 CN CN201710139222.5A patent/CN106912862A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105558968A (zh) * | 2016-01-28 | 2016-05-11 | 枣阳市圣奥养蜂专业合作社 | 灵芝黑蜂胶 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108056440A (zh) * | 2017-12-25 | 2018-05-22 | 云南保山嘉宏农业开发(集团)有限公司 | 印楝蜜的配方及其制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101999647B (zh) | 功能含化阿胶系列产品及其制备方法 | |
CN103555487B (zh) | 一种复方红葡萄酒的制造工艺 | |
CN102823653A (zh) | 系列复方保健药膳奶片及其制备方法 | |
CN103610035A (zh) | 一种海参营养口服液的制造方法 | |
CN105543052A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN106860680A (zh) | 金花人参压片糖果及其制备方法 | |
CN102630858A (zh) | 一种含中草药的复合型猪饲料 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN106798213A (zh) | 铁皮石斛保健饮料及其制作方法 | |
CN103610072A (zh) | 一种降血糖海参口服液的制造方法 | |
CN110151983A (zh) | 一种用于补肾益气的中药制剂及其制备方法 | |
CN103610077A (zh) | 一种海参胶囊 | |
CN109259219A (zh) | 一种鹿鞭蜜丸及其制备方法 | |
CN106923115A (zh) | 含西红花的植物饮料及其制备方法和应用 | |
CN109077306A (zh) | 一种缓解疲劳的组合物及其制备方法 | |
CN106107978A (zh) | 一种降血压无名葵保健口服液 | |
CN106912862A (zh) | 一种油茶蜂胶及其制备方法 | |
CN103461542B (zh) | 一种直接服用的月子油 | |
KR20120088264A (ko) | 한약재와 아카시아꿀을 이용한 건강보조식품 | |
KR20160064057A (ko) | Dha 함유 기억력 강화 및 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
CN105076414A (zh) | 一种适宜失眠人群饮用的酸奶及制法 | |
CN109112031A (zh) | 一种蜂蜜养生酒及其制备方法 | |
CN103933409A (zh) | 复方补骨脂黑发软胶丸 | |
CN103610068A (zh) | 一种降血脂海参口服液的制造方法 | |
CN103610112A (zh) | 一种增强免疫力的海参口服液及其使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170704 |
|
RJ01 | Rejection of invention patent application after publication |